Association between a specific apolipoprotein B mutation and familial defective apolipoprotein B-100

L. F. Soria, E. H. Ludwig, H. R G Clarke, Gloria L Vega, Scott M Grundy, B. J. McCarthy

Research output: Contribution to journalArticle

427 Citations (Scopus)

Abstract

Familial defective apolipoprotein (apo)B-100 is a genetic disease that leads to hypercholesterolemia and to an increased serum concentration of low density lipoproteins that bind defectively to the apoB,E(LDL) receptor. The disorder appears to result from a mutation in the gene for apoB-100. Extensive sequence analysis of the two alleles of one subject heterozygous for the disorder has revealed a previously unreported mutation in the codon for amino acid 3500 that results in the substitution of glutamine for arginine. This same mutant allele occurs in six other, unrelated subjects and in eight affected relatives in two of these families. A partial haplotype of this mutant apoB-100 allele was constructed by sequence analysis and restriction enzyme digestion at positions where variations in the apoB-100 are known to occur. This haplotype is the same in three probands and four affected members of one family and lacks a polymorphic Xba I site whose presence has been correlated with high cholesterol levels. Thus, it appears that the mutation in the codon for amino acid 3500 (CGC → CAG), a CG mutational 'hot spot', defines a minor apoB-100 allele associated with defective low density lipoproteins and hypercholesterolemia.

Original languageEnglish (US)
Pages (from-to)587-591
Number of pages5
JournalProceedings of the National Academy of Sciences of the United States of America
Volume86
Issue number2
StatePublished - 1989

Fingerprint

Apolipoprotein B-100
Hyperlipoproteinemia Type II
Apolipoproteins B
Hypercholesterolemia
Alleles
Mutation
LDL Lipoproteins
Codon
Haplotypes
Sequence Analysis
Amino Acids
Inborn Genetic Diseases
LDL Receptors
Glutamine
Arginine
Digestion
Enzymes
Serum
Genes

ASJC Scopus subject areas

  • General
  • Genetics

Cite this

Association between a specific apolipoprotein B mutation and familial defective apolipoprotein B-100. / Soria, L. F.; Ludwig, E. H.; Clarke, H. R G; Vega, Gloria L; Grundy, Scott M; McCarthy, B. J.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 86, No. 2, 1989, p. 587-591.

Research output: Contribution to journalArticle

@article{45d68adea7694e2086e2b8b349aeea20,
title = "Association between a specific apolipoprotein B mutation and familial defective apolipoprotein B-100",
abstract = "Familial defective apolipoprotein (apo)B-100 is a genetic disease that leads to hypercholesterolemia and to an increased serum concentration of low density lipoproteins that bind defectively to the apoB,E(LDL) receptor. The disorder appears to result from a mutation in the gene for apoB-100. Extensive sequence analysis of the two alleles of one subject heterozygous for the disorder has revealed a previously unreported mutation in the codon for amino acid 3500 that results in the substitution of glutamine for arginine. This same mutant allele occurs in six other, unrelated subjects and in eight affected relatives in two of these families. A partial haplotype of this mutant apoB-100 allele was constructed by sequence analysis and restriction enzyme digestion at positions where variations in the apoB-100 are known to occur. This haplotype is the same in three probands and four affected members of one family and lacks a polymorphic Xba I site whose presence has been correlated with high cholesterol levels. Thus, it appears that the mutation in the codon for amino acid 3500 (CGC → CAG), a CG mutational 'hot spot', defines a minor apoB-100 allele associated with defective low density lipoproteins and hypercholesterolemia.",
author = "Soria, {L. F.} and Ludwig, {E. H.} and Clarke, {H. R G} and Vega, {Gloria L} and Grundy, {Scott M} and McCarthy, {B. J.}",
year = "1989",
language = "English (US)",
volume = "86",
pages = "587--591",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "2",

}

TY - JOUR

T1 - Association between a specific apolipoprotein B mutation and familial defective apolipoprotein B-100

AU - Soria, L. F.

AU - Ludwig, E. H.

AU - Clarke, H. R G

AU - Vega, Gloria L

AU - Grundy, Scott M

AU - McCarthy, B. J.

PY - 1989

Y1 - 1989

N2 - Familial defective apolipoprotein (apo)B-100 is a genetic disease that leads to hypercholesterolemia and to an increased serum concentration of low density lipoproteins that bind defectively to the apoB,E(LDL) receptor. The disorder appears to result from a mutation in the gene for apoB-100. Extensive sequence analysis of the two alleles of one subject heterozygous for the disorder has revealed a previously unreported mutation in the codon for amino acid 3500 that results in the substitution of glutamine for arginine. This same mutant allele occurs in six other, unrelated subjects and in eight affected relatives in two of these families. A partial haplotype of this mutant apoB-100 allele was constructed by sequence analysis and restriction enzyme digestion at positions where variations in the apoB-100 are known to occur. This haplotype is the same in three probands and four affected members of one family and lacks a polymorphic Xba I site whose presence has been correlated with high cholesterol levels. Thus, it appears that the mutation in the codon for amino acid 3500 (CGC → CAG), a CG mutational 'hot spot', defines a minor apoB-100 allele associated with defective low density lipoproteins and hypercholesterolemia.

AB - Familial defective apolipoprotein (apo)B-100 is a genetic disease that leads to hypercholesterolemia and to an increased serum concentration of low density lipoproteins that bind defectively to the apoB,E(LDL) receptor. The disorder appears to result from a mutation in the gene for apoB-100. Extensive sequence analysis of the two alleles of one subject heterozygous for the disorder has revealed a previously unreported mutation in the codon for amino acid 3500 that results in the substitution of glutamine for arginine. This same mutant allele occurs in six other, unrelated subjects and in eight affected relatives in two of these families. A partial haplotype of this mutant apoB-100 allele was constructed by sequence analysis and restriction enzyme digestion at positions where variations in the apoB-100 are known to occur. This haplotype is the same in three probands and four affected members of one family and lacks a polymorphic Xba I site whose presence has been correlated with high cholesterol levels. Thus, it appears that the mutation in the codon for amino acid 3500 (CGC → CAG), a CG mutational 'hot spot', defines a minor apoB-100 allele associated with defective low density lipoproteins and hypercholesterolemia.

UR - http://www.scopus.com/inward/record.url?scp=0024558892&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024558892&partnerID=8YFLogxK

M3 - Article

VL - 86

SP - 587

EP - 591

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 2

ER -